Sandoz to expand biosimilar manufacturing in Germany
€25m funding is intended to unite a cutting-edge biotech lab and analytical expertise at Sandoz's German biosimilar manufacturing site.
Lendava Lendva Florian Bieber Development Platform Head Committee For Medicinal Products Human Use Biopharma Technical Development Bio European Commission
Source: europeanpharmaceuticalreview.com